Table 3.
Association between selected risk factors and superinfection
| Unadjusted |
Adjusted |
||||
|---|---|---|---|---|---|
| Factors | n/N | OR (95% CI) | P-value | OR (95% CI) | P-value |
| Maternal age | 0.86 | - | - | ||
| 17-24 yrs | 68/182 | 1 | |||
| ≥25 yrs | 114/182 | 0.89 (0.24-3.27) | |||
| Parity | 0.84 | - | - | ||
| 1-2 | 60/182 | 1 | |||
| >2 | 122/182 | 1.16 (0.29-4.64) | |||
| PEPI study arm | 0.19 | 0.45 | |||
| Control | 56/182 | 1 | 1 | ||
| Intervention | 126/182 | 0.42 (0.12-1.52) | 0.54 (0.11-2.71) | ||
| Baseline CD4 cell count, 100 cells/μL | 0.97 (0.69-1.34) | 0.84 | |||
| Baseline log10 VL | 0.46 (0.17-1.24) | 0.12 | 0.40 (0.13-1.19) | 0.10 | |
| Time to resumption of sexual activity, mos | 0.90 (0.73-1.11) | 0.32 | |||
| BF duration, mos | 0.78 (0.62-0.99) | 0.04 | 0.75 (0.56-1.00) | 0.05 | |
Abbreviations: N: total number of individuals; n: number of individuals with given trait; OR: odds ratio; CI: confidence intervals; PEPI: Post-exposure Prophylaxis of Infants in Malawi trial; VL: viral load; yrs; years; mos: months; BF: breastfeeding.